Pfizer (PFE) EV to EBITDA (2009 - 2026)
Pfizer's (PFE) EV to EBITDA stood at 4.71 in Q2 2026, up 1.6% from 4.64 a year earlier but down 7.5% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EV to EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Pfizer's EV to EBITDA came in at 3.17 as of Jun 28, 2026, up 10.7% year-over-year; for FY2025, it was 4.70, down 10.5% from FY2024.
- Across earlier years, EV to EBITDA came in at 5.25 in FY2024 (-56.4%), 12.02 in FY2023 (+105.6%), 5.84 in FY2022 (-38.3%) and 9.48 in FY2021 (-16.9%).
- Quarterly EV to EBITDA has ranged from 4.47 in Q3 2025 to 10.31 in Q4 2021 over the past five years.
- On a year-over-year basis, EV to EBITDA rose in 1 of the last seven quarters, with an average decline of 24.8%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 120.3% in Q2 2024, against a decline of 54.5% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 5.09 (Q1 2026), 4.69 (Q4 2025) and 4.47 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 4.71 |
| Mar 29, 2026 | 5.09 |
| Dec 31, 2025 | 4.69 |
| Sep 28, 2025 | 4.47 |
| Jun 29, 2025 | 4.64 |
| Mar 30, 2025 | 5.21 |
| Dec 31, 2024 | 5.25 |
| Sep 29, 2024 | 8.64 |
| Jun 30, 2024 | 10.19 |
| Mar 31, 2024 | 7.26 |
| Dec 31, 2023 | 7.64 |
| Jul 2, 2023 | 4.62 |
| Apr 2, 2023 | 5.02 |
| Dec 31, 2022 | 7.00 |
| Jul 3, 2022 | 6.45 |
| Apr 3, 2022 | 7.77 |
| Dec 31, 2021 | 10.31 |
| Oct 3, 2021 | 7.75 |
| Jul 4, 2021 | 8.90 |
| Apr 4, 2021 | 10.15 |
API Access
Pfizer EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();